|
|
PRAX
|
Stock |
Healthcare
|
US$ 9,82 B
|
5,24% |
|
|
DNTH
|
Stock |
Healthcare
|
US$ 5,91 B
|
4,99% |
|
|
ACAD
|
Stock |
Healthcare
|
US$ 4,83 B
|
4,91% |
|
|
SRRK
|
Stock |
Healthcare
|
US$ 6,74 B
|
4,76% |
|
|
XENE
|
Stock |
Healthcare
|
US$ 5,85 B
|
4,37% |
|
|
ARGX
|
Stock |
Healthcare
|
US$ 65,51 B
|
4,35% |
|
|
ARWR
|
Stock |
Healthcare
|
US$ 12,20 B
|
4,27% |
|
|
BIIB
|
Stock |
Healthcare
|
US$ 32,63 B
|
4,17% |
|
|
ALKS
|
Stock |
Healthcare
|
US$ 7,73 B
|
4,16% |
|
|
PTCT
|
Stock |
Healthcare
|
US$ 5,78 B
|
3,75% |
|
|
NBIX
|
Stock |
Healthcare
|
US$ 15,82 B
|
3,60% |
|
|
DNLI
|
Stock |
Healthcare
|
US$ 3,56 B
|
3,48% |
|
|
EWTX
|
Stock |
Healthcare
|
US$ 4,56 B
|
3,33% |
|
|
DYN
|
Stock |
Healthcare
|
US$ 4,53 B
|
3,33% |
|
|
AXSM
|
Stock |
Healthcare
|
US$ 10,91 B
|
3,29% |
|
|
AXGN
|
Stock |
Healthcare
|
US$ 2,53 B
|
2,59% |
Sk Biopharmaceuticals Co Ltd
|
326030
|
Stock |
Healthcare
|
US$ 6,78 T
|
2,55% |
|
|
SUPN
|
Stock |
Healthcare
|
US$ 2,53 B
|
2,39% |
|
|
SRPT
|
Stock |
Healthcare
|
US$ 2,43 B
|
2,17% |
Biohaven Ltd.
|
BHVN
|
Stock |
Healthcare
|
US$ 2,37 B
|
1,99% |
H Lundbeck A/S
|
HLUN-B
|
Stock |
Healthcare
|
US$ 43,77 B
|
1,80% |
|
|
NEU
|
Stock |
Healthcare
|
US$ 2,58 B
|
1,57% |
BioArctic AB (publ)
|
BIOA-B
|
Stock |
Healthcare
|
US$ 29,64 B
|
1,43% |
Rapport Therapeutics, Inc. Common Stock
|
RAPP
|
Stock |
Healthcare
|
US$ 2,20 B
|
1,39% |
|
|
TSHA
|
Stock |
Healthcare
|
US$ 1,81 B
|
1,36% |
Idorsia Ltd
|
IDIA
|
Stock |
Healthcare
|
US$ 1,39 B
|
1,12% |
|
|
IART
|
Stock |
Healthcare
|
US$ 1,30 B
|
1,11% |
Alto Neuroscience, Inc.
|
ANRO
|
Stock |
Healthcare
|
US$ 1,40 B
|
1,11% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX
|
Stock |
Healthcare
|
US$ 1,53 B
|
0,98% |
|
|
SLDB
|
Stock |
Healthcare
|
US$ 1,10 B
|
0,78% |
|
Dynavox Group
|
DYVOX
|
Stock |
Healthcare
|
US$ 8,17 B
|
0,77% |
|
|
ANNX
|
Stock |
Healthcare
|
US$ 917,56 M
|
0,70% |
|
Oncolys Biopharma Inc
|
4588
|
- |
Healthcare
|
-
|
0,67% |
Medincell SA
|
MEDCL
|
Stock |
Healthcare
|
US$ 818,74 M
|
0,65% |
CeriBell, Inc
|
CBLL
|
Stock |
Healthcare
|
US$ 948,71 M
|
0,61% |
|
|
DSGN
|
Stock |
Healthcare
|
US$ 940,60 M
|
0,57% |
|
Bright Minds Biosciences Inc
|
DRUG
|
Stock |
Healthcare
|
US$ 697,83 M
|
0,54% |
|
|
CAPR
|
Stock |
Healthcare
|
US$ 546,51 M
|
0,53% |
|
Neurogene Inc
|
NGNE
|
Stock |
Healthcare
|
US$ 772,44 M
|
0,48% |
|
|
OVID
|
Stock |
Healthcare
|
US$ 542,93 M
|
0,46% |
|
|
PRTA
|
Stock |
Healthcare
|
US$ 504,13 M
|
0,45% |
|
|
RGNX
|
Stock |
Healthcare
|
US$ 607,32 M
|
0,44% |
|
|
BWAY
|
Stock |
Healthcare
|
US$ 568,94 M
|
0,42% |
|
|
BNTC
|
Stock |
Healthcare
|
US$ 427,37 M
|
0,42% |
|
|
RLMD
|
Stock |
Healthcare
|
US$ 466,15 M
|
0,41% |
|
|
CLPT
|
Stock |
Healthcare
|
US$ 425,84 M
|
0,40% |
Neuropace Inc
|
NPCE
|
Stock |
Healthcare
|
US$ 506,28 M
|
0,39% |
|
Zylox-Tonbridge Med Tech Co
|
2190
|
Stock |
Healthcare
|
US$ 7,28 B
|
0,37% |
|
Sanbio Company Limited
|
4592
|
- |
Healthcare
|
-
|
0,34% |
|
MicroPort NeuroTech Ltd
|
2172
|
Stock |
Healthcare
|
US$ 4,58 B
|
0,33% |
|
|
VNDA
|
Stock |
Healthcare
|
US$ 322,87 M
|
0,31% |
|
Peijia Medical Ltd
|
9996
|
Stock |
Healthcare
|
US$ 3,38 B
|
0,30% |
|
Newron Pharmaceuticals SpA
|
NWRN
|
Stock |
Healthcare
|
US$ 250,09 M
|
0,27% |
|
|
AVXL
|
Stock |
Healthcare
|
US$ 265,11 M
|
0,26% |
|
Santhera Pharmaceuticals Holding AG
|
SANN
|
Stock |
Healthcare
|
US$ 239,11 M
|
0,24% |
|
|
IKT
|
Stock |
Healthcare
|
US$ 348,84 M
|
0,23% |
|
|
TNXP
|
Stock |
Healthcare
|
US$ 229,31 M
|
0,23% |
|
|
LRMR
|
Stock |
Healthcare
|
US$ 397,87 M
|
0,20% |
|
|
ALEC
|
Stock |
Healthcare
|
US$ 274,68 M
|
0,20% |
|
|
ABOS
|
Stock |
Healthcare
|
US$ 223,46 M
|
0,19% |
PepGen Ltd
|
PEPG
|
Stock |
Healthcare
|
US$ 220,99 M
|
0,19% |
|
|
VYGR
|
Stock |
Healthcare
|
US$ 208,27 M
|
0,18% |
|
|
ACIU
|
Stock |
Healthcare
|
US$ 291,32 M
|
0,17% |
Entrada Therapeutics Inc
|
TRDA
|
Stock |
Healthcare
|
US$ 279,18 M
|
0,16% |
|
MYUNG IN PHARMA CO LTD
|
317450
|
Stock |
Healthcare
|
US$ 651,89 B
|
0,12% |
|
MapLight Therapeutics, Inc. Common Stock
|
MPLT
|
Stock |
Healthcare
|
US$ 638,62 M
|
0,10% |
Neumora Therapeutics, Inc.
|
NMRA
|
Stock |
Healthcare
|
US$ 253,66 M
|
0,10% |
Cognition Therapeutics Inc
|
CGTX
|
Stock |
Healthcare
|
US$ 97,95 M
|
0,08% |